Research > ETFs > ETF / ETP Commentary > 

1 Year of DRNZ: A Closer Look at Defense ETFs

Thursday, October 29 is a big day for the REX Drone ETF (DRNZ). After all, this is the one-year anniversary for DRNZ, which launched on October 29, 2025.Key Takeaways: On Thursday, October 29, the REX Drone ETF (DRNZ) is celebrating its one-year anniversary. When looking under the hood of the fund’s approach, DRNZ offers vastly different investment exposure compared to a more traditional defense fund like the Invesco Aerospace & Defense ETF (PPA). Given that these two ETFs differ in geographic and market-cap exposure, they can work well in a conjoined portfolio. While timing the market is rarely deliberate, DRNZ ended up coming to the market ahead of a critical geopolitical moment. Tensions in Iran reached a boiling point at the end of February 2026, leading the public and private sector to look at the defense industry in a new light. Though the defense industry may be seeing increased attention as a whole, there are many different ways to construct one’s exposure to the industry. As an example, take a look at how DRNZ differentiates itself from something like the Invesco Aerospace & Defense ETF (PPA A-). See More: Why Invest in Defense? The Case for Targeted ExposureSame Industry, Different InvestmentsTo start, these funds already offer different investment focuses and philosophies. PPA is a broad fund that invests in a variety of different companies engaged in defense, aerospace, homeland security, space, and more. Meanwhile, DRNZ is a more specialized fund, allocating toward companies engaged in the drone and UAV industry. Furthermore, the funds diverge when it comes to geographic exposure. DRNZ is a global fund, while PPA primarily focuses on U.S. defense companies. The differences don’t stop with geography and investment thesis, either. DRNZ’s nuanced investment philosophy has led it toward a number of small- and midcap companies, such as Ondas and DroneShield, as of October 26, 2026. Meanwhile, PPA holds a number of key large-cap defense names, like Lockheed Martin, RTX, and Boeing, as of October 26, 2026. See More: 4Q26 Defense Sector Guide – Opportunities Amid InstabilityUse Case for DRNZ & PPAThese differences don’t require choosing one over the other. If anything, they make a strong case for owning both. With DRNZ and PPA offering contrasting market-cap exposure and geographic focus, the two funds complement each other well. Above all, defense ETFs are far less uniform than many investors assume, making it essential to look under the hood at fund composition before committing capital. And with the defense industry well-positioned to continue seeing interest and capital in the coming months, maintaining targeted exposure through a few ETFs could make sense. For more news, information, and analysis, visit the Investing in Defense Content Hub. Invesco Distributors, Inc. is an independent company unaffiliated with VettaFi LLC (“VettaFi”). These articles do not form any kind of legal partnership, agency affiliation, or similar relationship between VettaFi and Invesco Distributors, Inc., nor is such a relationship created or implied by the articles herein. VettaFi LLC is the author and owner of these articles. VettaFi LLC (“VettaFi”) is the index provider for PPA and DRNZ, for which it receives an index licensing fee. However, PPA and DRNZ are not issued, sponsored, endorsed, or sold by VettaFi, and VettaFi has no obligation or liability in connection with the issuance, administration, marketing, or trading of PPA and DRNZ.

Performance data shown is past performance and is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore you have a gain or loss when you sell your shares. For standard quarterly performance, go to the fund's Snapshot page by clicking on the ETF/ETP's symbol.

ETFs may trade at a premium or discount to their NAV and are subject to the market fluctuations of their underlying investments.

For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain FBS platforms and investment programs. Please note, this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral. Additional information about the sources, amounts, and terms of compensation can be found in the ETF's prospectus and related documents. Fidelity may add or waive commissions on ETFs without prior notice. BlackRock and iShares are registered trademarks of BlackRock, Inc. and its affiliates.

FBS receives compensation from the fund's advisor or its affiliates in connection with a marketing program that includes the promotion of this security and other ETFs to customers ("Marketing Program"). The Marketing Program creates incentives for FBS to encourage the purchase of certain ETFs. Additional information about the sources, amounts, and terms of compensation is in the ETF's prospectus and related documents. Please note that this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral.

News, commentary (including "Related Symbols") and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended to help self-directed investors evaluate exchange traded products (ETPs), including, but limited to exchange traded funds (ETFs) and exchange traded notes (ETNs). Criteria and inputs entered, including the choice to make ETP comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating ETPs. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.

Before investing in any exchange traded product, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for a prospectus, offering circular or, if available, a summary prospectus containing this information. Read it carefully.